BRAINTREE, Mass. (AP) -- Health care company Haemonetics has conducted a 2-for-1 split of its common shares.
The company said Monday that the stock split did not alter any shareholders' ownership percentage.
Haemonetics said that it expects the stock split will make its shares more accessible and increase its stockholder base, which will improve its market liquidity.
The company's stock began trading on a post-split basis on the New York Stock Exchange on Monday.
Shares of Haemonetics Corp., which helps in managing blood supplies, added 34 cents to $40.85 in afternoon trading.
- Investment & Company Information